288 related articles for article (PubMed ID: 36799184)
1. Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers (Review).
Lei X; Hu X; Lu Q; Fu W; Sun W; Ma Q; Huang D; Xu Q
Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36799184
[TBL] [Abstract][Full Text] [Related]
2. Role of long non-coding RNA H19 in therapy resistance of digestive system cancers.
Wang J; Ma X; Si H; Ma Z; Ma Y; Wang J; Cao B
Mol Med; 2021 Jan; 27(1):1. PubMed ID: 33402118
[TBL] [Abstract][Full Text] [Related]
3. Diverse roles of UBE2T in cancer (Review).
Ma N; Li Z; Yan J; Liu X; He L; Xie R; Lu X
Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36825587
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of UCA1 for predicting clinical outcome in patients with digestive system malignancies.
Liu FT; Dong Q; Gao H; Zhu ZM
Oncotarget; 2017 Jun; 8(25):40620-40632. PubMed ID: 28380443
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of pretreatment plasma fibrinogen level in patients with digestive system tumors: a meta-analysis.
Ji R; Ren Q; Bai S; Wang Y; Zhou Y
Int J Biol Markers; 2018 Aug; 33(3):254-265. PubMed ID: 29874984
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA is a popular molecule in tumors of the digestive system (Review).
Wang HY; Wang YP; Zeng X; Zheng Y; Guo QH; Ji R; Zhou YN
Int J Oncol; 2020 Jul; 57(1):21-42. PubMed ID: 32377736
[TBL] [Abstract][Full Text] [Related]
7. Sialylated glycoproteins and sialyltransferases in digestive cancers: Mechanisms, diagnostic biomarkers, and therapeutic targets.
Zhang SZ; Lobo A; Li PF; Zhang YF
Crit Rev Oncol Hematol; 2024 May; 197():104330. PubMed ID: 38556071
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
[TBL] [Abstract][Full Text] [Related]
9. The prognostic potential of long noncoding RNA HOTAIR expression in human digestive system carcinomas: A meta-analysis.
Abdeahad H; Avan A; Pashirzad M; Khazaei M; Soleimanpour S; Ferns GA; Fiuji H; Ryzhikov M; Bahrami A; Hassanian SM
J Cell Physiol; 2019 Jul; 234(7):10926-10933. PubMed ID: 30569489
[TBL] [Abstract][Full Text] [Related]
10. [Biomarkers for neoplasmas in digestive organs].
Iwasaki Y; Arai K; Katayanagi S; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1015-20. PubMed ID: 15272578
[TBL] [Abstract][Full Text] [Related]
11. E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions.
Hosseini SM; Okoye I; Chaleshtari MG; Hazhirkarzar B; Mohamadnejad J; Azizi G; Hojjat-Farsangi M; Mohammadi H; Shotorbani SS; Jadidi-Niaragh F
Clin Chim Acta; 2019 Nov; 498():126-134. PubMed ID: 31445029
[TBL] [Abstract][Full Text] [Related]
12. The Impact of MicroRNA-133a on Prognosis and Clinicopathological Parameters for Digestive System Cancers: a Comprehensive Study Based on Meta-Analysis and TCGA Database.
Zhu W; Ji X
Pathol Oncol Res; 2020 Apr; 26(2):771-781. PubMed ID: 30810894
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact.
Tsunedomi R; Yoshimura K; Suzuki N; Hazama S; Nagano H
Surg Today; 2020 Dec; 50(12):1560-1577. PubMed ID: 32025858
[TBL] [Abstract][Full Text] [Related]
14. "OMICS" technologies and their role in foregut primary malignancies.
Farid SG; Morris-Stiff G
Curr Probl Surg; 2015 Oct; 52(10):409-41. PubMed ID: 26527526
[No Abstract] [Full Text] [Related]
15. UBE2C is involved in the functions of ECRG4 on esophageal squamous cell carcinoma.
Li L; Li X; Wang W; Gao T; Shi Z
Biomed Pharmacother; 2018 Feb; 98():201-206. PubMed ID: 29268240
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-145 and Its Direct Downstream Targets in Digestive System Cancers: A Promising Therapeutic Target.
Ma Y; Cao X; Shi G; Shi T
Curr Pharm Des; 2021; 27(19):2264-2273. PubMed ID: 33121400
[TBL] [Abstract][Full Text] [Related]
17. Somatic gene mutation signatures predict cancer type and prognosis in multiple cancers with pan-cancer 1000 gene panel.
Wang HL; Liu PF; Yue J; Jiang WH; Cui YL; Ren H; Wang H; Zhuang Y; Liu Y; Jiang D; Dong Q; Zhang H; Mi JH; Xu ZM; Tian CJ; Zhang ZZ; Wang XW; Su MN; Lu W
Cancer Lett; 2020 Feb; 470():181-190. PubMed ID: 31765737
[TBL] [Abstract][Full Text] [Related]
18. Stratification of Digestive Cancers with Different Pathological Features and Survival Outcomes by MicroRNA Expression.
Tang S; Wu WK; Li X; Wong SH; Wong N; Chan MT; Sung JJ; Yu J
Sci Rep; 2016 Apr; 6():24466. PubMed ID: 27080237
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding small nucleolar RNA host genes in digestive cancers.
Yang H; Jiang Z; Wang S; Zhao Y; Song X; Xiao Y; Yang S
Cancer Med; 2019 Dec; 8(18):7693-7704. PubMed ID: 31691514
[TBL] [Abstract][Full Text] [Related]
20. E2F transcription factors and digestive system malignancies: how much do we know?
Xanthoulis A; Tiniakos DG
World J Gastroenterol; 2013 Jun; 19(21):3189-98. PubMed ID: 23745020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
